- Low Pill Burden: Streamlined once-daily dosing supports adherence1
- Superior Efficacy: HbA1c reduced by up to 2.1%, outperforming monotherapy2
- Enhanced Tolerability: Sustained-release formulation minimizes GI side effects often linked to metformin.3
References:
1. Package Insert of Zemimet SR.
2. Lim S et al., Diabetes Obes Metab. 2017;19(1):87-97.
3. Foster RH et al., Am J Drug Deliv. 2006;4(3):177-186.
For healthcare professionals only.
PHARMANIAGA MARKETING SDN BHD
Company No: 198401005734
No. 7 Lorong Keluli 1B, Kawasan Perindustrian Bukit, Raja Selatan, Seksyen 7,
Selangor Darul Ehsan 40000
Tel: (+60) 3342 9999 • Fax: (+60) 3341 7777